2Henriques JP, Zijlstra F, Otervanger JP, et al. Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur Heart J, 2002, 23:1112～1117.
3Giri S, Mitchel JF, Hirst JA, et al. Synrgy between intracoro nary stenting and abciximab in improving angiographic and clinical outcomes of primary angioplasty in acute myocardial infarction.Am JCardiol, 2000, 86: 269～274.
4Kloner RA, Ganote CE, Jennings RS. The"no-flow" phenomenon following temporary coronary occlusion in the dog. J Clin Invest, 1974, 54: 1496～1508.
5Seydoux C, Goy JJ, Davies G. Platelet and neutrophic imaging techniques in the investingation of the response to thrombolytic herapy and the no-reflow phenomenon. AM Heart J, 1993,125: 1142～1147.
6Abbo KM, Doorism, Glazier S, et al. Features and outcome of no-reflow after precutaneous coronary intervention. Am J Cardiol, 1995, 75: 778～782.
7Fischell TA, Carter A, Foster MT, et al. Reversal of "noflow" during vein graft stenting using high velocity boluses of intracoronary adeosine. Catheterisation & Cardiovascular Diagnosis, 1998, 45: 360～365.
8Mark Kb, Challapalli R, Eisenberg MI, et al. Effect of platelet glycoprotein Ⅱ b/Ⅲ a receptor inhibition distal embolization during precutaneous revascularization of aorocoronary saphenous vein grafts. AmJ ardiol, 1997, 80: 985～988.
9Rawilscher D, Levin Tn, Cohen I, et al. Rapid reversal of noflow using Abciximab after coronary device intervention. Catheterisation & Cardiovascular Diagnosis, 1997, 42 (2): 187 ～190.
10Sutsch G, Kiowski W, Bossard A. Use of an emboli containment and retrieval system during percutaneons coronary angioplasty in native coronary arteries. Schweiz Med Wochenschr,2000, 130 (33): 1135～1145.
二级参考文献9
1Morishima 1, Sone T, Okumura K, et al, Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. JACC, 2000,36:1202-1209.
2Tanaka A, Kawarabayashi T, Nishibori Y, et al, No-reflow phenomenon and lesion morphology in patients with acute myocardial infarction. Circulation, 2002, 105:2148-2152.
3vHof AM J, Liem A, Suryapranata H, et al, Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial brush grade. Circulation,1998,97 : 2302-2306.
4Iwakura K, Ito H, Nishikawa N, et al, Early temporal changes in coronary flow velocity patterns in patients with acute myocardial infarction demonstrating the “no-reflow” phenomenon. Am J Cardiol,1999,84:415-419.
7Michaels AD, Gibson CM, Barton HW. Microvascnlar dysfunction in acute myocardial infarction: focus on the roles of platelet and inflammatory mediators in the no-reflow phenomenon. Am J Cardiol,2000,85:50B-60B.
8Bain DS, Wahr D, George B, et al, Randomized trial of a distal embolic protection device during percutaneous interven of saphenous vein aorto-coronary bypass grafts. Circulalion, 2002,105:r13-r18.
9U.S. SAPPHIRE Study Group. Preliminary results of carotid stenting with ANGIOGUARD XP emboli protection guidewire vs. surgery for carotid artery blockages in high risk patients. AHA, 2002,11, chicago,IL.
